17 April 2024 - International regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine ...
9 April 2024 - Final draft guidance for remdesivir and for tixagevimab with cilgavimab has been published by NICE. ...
29 February 2024 - The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation ...
22 February 2024 - Joint media release with Health New Zealand. ...
10 February 2024 - Approval of a change to the licence of Comirnaty COVID-19 vaccine will enable thawing and re-labelling of ...
18 January 2024 - NICE has published additional draft guidance on the use of remdesivir and the combination of tixagevimab ...
18 January 2024 - Draft guidance for public consultation has been published by NICE. ...
11 January 2024 - A further 1.4 million people who have an increased risk for progression to severe COVID-19 will be ...
18 December 2023 - The manufacturer Novavax is no longer pursuing marketing authorisation for its COVID-19 vaccine in Switzerland. ...
20 December 2023 - A vaccine to combat the newer strains of COVID-19 has been approved and will be available ...
19 December 2023 - On the last day of November Texas launched extraordinary legal proceedings that could have wide-ranging political ...
6 December 2023 - As New Zealand’s response to the COVID-19 pandemic has evolved, so has ours. ...
1 December 2023 - The European Medicines Regulatory Network has been at the forefront of the fight against COVID-19 with ...
27 November 2023 - Exclusive Partner in Japan, Meiji Seika Pharma advances regulatory approval. ...
28 November 2023 - - Daiichi Sankyo today announced that Daichirona for intramuscular injection (DS-5670) for booster vaccination has been ...